Literature DB >> 33424968

Vitamin D Supplementation Ameliorates Metabolic Dysfunction in Patients with PCOS: A SystematicReview of RCTs and Insight into the Underlying Mechanism.

Shan Guo1, Reshef Tal2, Haoyu Jiang3, Tao Yuan1, Ying Liu1.   

Abstract

OBJECTIVE: Evidence suggests that vitamin D deficiency correlated with metabolic disorders in women with polycystic ovary syndrome (PCOS). We conducted this systematic review and meta-analysis to evaluate the impact of vitamin D supplementation alone on glucose, lipid, and androgen parameters and inflammation biomarkers in women with PCOS.
METHODS: Literature research was conducted in Pubmed, Embase, Web of Science, Clinical Trials, and Cochrane Library to identify relevant randomized controlled trials (RCTs) up to March 2020. The effect of vitamin D supplementation alone on women with PCOS was compared with administration of placebo. The systematic review and meta-analysis protocol was registered in the International Prospective Register of Systematic Reviews (Prospero) as number CRD42020157444.
RESULTS: Thirteen randomized controlled trials with 824 patients in total were included. Serum FPG, fasting insulin, HOMA-IR, and VLDL-C were significantly decreased in the vitamin D group versus placebo. Vitamin D supplementation group also showed a significantly elevated level of QUICKI. No significant impact was seen on serum triglyceride, total-C, LDL-C, HDL-C, total testosterone, DHEAS, SHBG, or hs-CRP. Subgroup analysis demonstrated that oral vitamin D intake had significantly decreased serum triglyceride and total-C level in women with PCOS who have vitamin D deficiency (serum vitamin D < 20 ng/ml).
CONCLUSION: The findings of the present meta-analysis indicate that vitamin D supplementation exerted favorable effects among women with PCOS on glucose metabolism and lipid metabolism, especially in vitamin D deficient women, but had no significant effect on the androgenic profile or inflammation status.
Copyright © 2020 Shan Guo et al.

Entities:  

Year:  2020        PMID: 33424968      PMCID: PMC7773476          DOI: 10.1155/2020/7850816

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


  38 in total

1.  Circulating transforming growth factor beta 1 and coronary artery disease.

Authors:  X L Wang; S X Liu; D E Wilcken
Journal:  Cardiovasc Res       Date:  1997-05       Impact factor: 10.787

Review 2.  Relevance of vitamin D in reproduction.

Authors:  Janelle Luk; Saioa Torrealday; Genevieve Neal Perry; Lubna Pal
Journal:  Hum Reprod       Date:  2012-07-23       Impact factor: 6.918

Review 3.  Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Fang Fang; Ke Ni; Yiting Cai; Jin Shang; Xiaoke Zhang; Chengliang Xiong
Journal:  Complement Ther Clin Pract       Date:  2016-11-25       Impact factor: 2.446

4.  Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Fatemeh Foroozanfard; Mehri Jamilian; Fereshteh Bahmani; Rezvan Talaee; Naeeme Talaee; Teibeh Hashemi; Khadijeh Nasri; Zatollah Asemi; Ahmad Esmaillzadeh
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-23       Impact factor: 3.478

Review 5.  The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.

Authors:  Maryam Azadi-Yazdi; Azadeh Nadjarzadeh; Hossein Khosravi-Boroujeni; Amin Salehi-Abargouei
Journal:  Horm Metab Res       Date:  2017-03-28       Impact factor: 2.936

6.  The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Maryam Maktabi; Maryam Chamani; Zatollah Asemi
Journal:  Horm Metab Res       Date:  2017-07-05       Impact factor: 2.936

7.  Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.

Authors:  Mohamad Irani; David B Seifer; Richard V Grazi; Sara Irani; Zev Rosenwaks; Reshef Tal
Journal:  Nutrients       Date:  2017-03-28       Impact factor: 5.717

8.  Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study.

Authors:  Y H M Krul-Poel; P P Koenders; R P Steegers-Theunissen; E Ten Boekel; M M Ter Wee; Y Louwers; P Lips; J S E Laven; S Simsek
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

9.  A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

Authors:  Zeeshan Javed; Maria Papageorgiou; Harshal Deshmukh; Eric S Kilpatrick; Vincent Mann; Lynsey Corless; George Abouda; Alan S Rigby; Stephen L Atkin; Thozhukat Sathyapalan
Journal:  Nutrients       Date:  2019-01-17       Impact factor: 5.717

10.  Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial.

Authors:  Christian Trummer; Verena Schwetz; Martina Kollmann; Monika Wölfler; Julia Münzker; Thomas R Pieber; Stefan Pilz; Annemieke C Heijboer; Barbara Obermayer-Pietsch; Elisabeth Lerchbaum
Journal:  Eur J Nutr       Date:  2018-06-26       Impact factor: 5.614

View more
  7 in total

Review 1.  Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms.

Authors:  Roghaye Gharaei; Forough Mahdavinezhad; Esmaeil Samadian; Jahanbakhsh Asadi; Zhaleh Ashrafnezhad; Ladan Kashani; Fardin Amidi
Journal:  J Assist Reprod Genet       Date:  2021-11       Impact factor: 3.412

Review 2.  Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.

Authors:  Giorgia Scarfò; Simona Daniele; Jonathan Fusi; Marco Gesi; Claudia Martini; Ferdinando Franzoni; Vito Cela; Paolo Giovanni Artini
Journal:  Biomedicines       Date:  2022-06-02

Review 3.  Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome.

Authors:  Simon Alesi; Carolyn Ee; Lisa J Moran; Vibhuti Rao; Aya Mousa
Journal:  Adv Nutr       Date:  2022-08-01       Impact factor: 11.567

Review 4.  Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment.

Authors:  Chuan Xing; Jiaqi Zhang; Han Zhao; Bing He
Journal:  Int J Womens Health       Date:  2022-02-02

Review 5.  The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility.

Authors:  Yu-Qian Shi; Yi Wang; Xi-Ting Zhu; Rui-Yang Yin; Yi-Fu Ma; Han Han; Yan-Hua Han; Yue-Hui Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-07       Impact factor: 2.650

Review 6.  A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.

Authors:  Rajeshwari Kalyanaraman; Lubna Pal
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

Review 7.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.